Zu "849217-64-7" wurden 4 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Foretinib
Artikelnummer: TGM-T3113-100mg
Description: Foretinib (GSK1363089) is a broad-spectrum tyrosine kinase inhibitor with IC50s of 0.4 nM and 0.9 nM for Met and KDR. Target: Tie-2, c-Met/HGFR, VEGFR. Smiles: COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1. References: Qian F, et al. Inhibition of tumor cell growth,...
| Schlagworte: | EXEL-2880, GSK1363089, XL880, GSK089 |
| Anwendung: | Targets kinase insert domain protein receptor [EC:2.7.10.1] (KDR, VEGFR2, CD309) |
| CAS | 849217-64-7 |
| MW: | 632.65 D |
ab 34,00 €
Foretinib
Artikelnummer: Cay16249-1
Foretinib is a broad-spectrum tyrosine kinase (TK) inhibitor that targets members of the HGF and VEGF receptor TK families, as well as KIT, Flt-3, PDGFRbeta, and Tie-2, at nanomolar concentrations. It blocks HGF-induced Met phosphorylation and VEGF-induced ERK phosphorylation, preventing HGF-induced responses in...
| Schlagworte: | GSK1363089, XL880,... |
| Anwendung: | VEGFR2 / MET inhibitor |
| CAS | 849217-64-7 |
| MW: | 632.7 D |
ab 44,00 €
Foretinib
Artikelnummer: LKT-F5968.5
Foretinib is an inhibitor of ROS1, MET, Ron, Axl, Tie-2, and VEGFR2 that exhibits anticancer chemotherapeutic and anti-angiogenic activities. In subjects with squamous cell carcinoma, foretinib decreases tumor size. In hepatocellular carcinoma cells, foretinib increases expression of p27 and Bim, decreases...
| Schlagworte: | GSK-1363089, GSK1363089 |
| Anwendung: | VEGFR2 tyrosine kinase inhibitor, Met proto-oncogene (c-Met) inhibitor |
| CAS | 849217-64-7 |
| MW: | 632.65 D |
ab 151,00 €
Foretinib
Artikelnummer: SYN-1129-M001
Soluble in DMSO. Foretinib is a novel MET and VEGFR2 kinase inhibitor with IC(50) values of 0.4 and 0.8nM for MET and VEGFR2 respectively. Target: VEGFR2 - MET , Kinase Group: RTK , Substrate: Tyrosine
| Schlagworte: | GSK-1363089, EXEL-2880 |
| Anwendung: | VEGFR2 / MET inhibitor |
| CAS | 849217-64-7 |
| MW: | 632,7 D |
ab 162,00 €
